177 related articles for article (PubMed ID: 28718365)
1. TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
Zhang X; Wan JX; Ke ZP; Wang F; Chai HX; Liu JQ
Tumour Biol; 2017 Jul; 39(7):1010428317708900. PubMed ID: 28718365
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
4. The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
Cao J; Hou P; Chen J; Wang P; Wang W; Liu W; Liu C; He X
Tumour Biol; 2017 Jun; 39(6):1010428317705753. PubMed ID: 28631558
[TBL] [Abstract][Full Text] [Related]
5. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
6. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
Chen Q; Qiu XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):522-527. PubMed ID: 28468075
[No Abstract] [Full Text] [Related]
7. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
8. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance.
Gao XQ; Ge YS; Shu QH; Ma HX
Tumour Biol; 2017 Jun; 39(6):1010428317709635. PubMed ID: 28653890
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
12. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Liu T; Kan XF; Ma C; Chen LL; Cheng TT; Zou ZW; Li Y; Cao FJ; Zhang WJ; Yao J; Li PD
Tumour Biol; 2017 Jun; 39(6):1010428317700410. PubMed ID: 28635398
[TBL] [Abstract][Full Text] [Related]
13. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
Pu M; Wang J; Huang Q; Zhao G; Xia C; Shang R; Zhang Z; Bian Z; Yang X; Tao K
Tumour Biol; 2017 Jul; 39(7):1010428317709127. PubMed ID: 28714366
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
15. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.
Ouyang J; Sun Y; Li W; Zhang W; Wang D; Liu X; Lin Y; Lian B; Xie L
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2688-95. PubMed ID: 26940364
[TBL] [Abstract][Full Text] [Related]
16. CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis.
Zhu M; Xu W; Wei C; Huang J; Xu J; Zhang Y; Zhao Y; Chen J; Dong S; Liu B; Liang C
Cell Death Dis; 2019 Oct; 10(11):796. PubMed ID: 31641099
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
18. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Jiao Y; Li Y; Ji B; Cai H; Liu Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
[TBL] [Abstract][Full Text] [Related]
19. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
Li X; Xu W; Kang W; Wong SH; Wang M; Zhou Y; Fang X; Zhang X; Yang H; Wong CH; To KF; Chan SL; Chan MTV; Sung JJY; Wu WKK; Yu J
Theranostics; 2018; 8(6):1740-1751. PubMed ID: 29556353
[No Abstract] [Full Text] [Related]
20. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.
Teng L; Wang K; Liu Y; Ma Y; Chen W; Bi L
Biomed Res Int; 2019; 2019():1742341. PubMed ID: 31886176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
